Prognostic effect of class III β-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors.

about

Prognostic effect of class III β-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors.

Item

http://www.wikidata.org/entity/Q41143898

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Prognostic effect of class III ...... r topoisomerase-II inhibitors.

@en

type

Item

label

Prognostic effect of class III ...... r topoisomerase-II inhibitors.

@en

prefLabel

Prognostic effect of class III ...... r topoisomerase-II inhibitors.

@en

P1476

Prognostic effect of class III ...... r topoisomerase-II inhibitors.

@en

P2093

Hisao Imai

http://www.w3.org/2001/XMLSchema#string

Koichi Minato

http://www.w3.org/2001/XMLSchema#string

Kyoichi Kaira

http://www.w3.org/2001/XMLSchema#string

Masanobu Yamada

http://www.w3.org/2001/XMLSchema#string

Noriaki Sunaga

http://www.w3.org/2001/XMLSchema#string

Reiko Sakurai

http://www.w3.org/2001/XMLSchema#string

Takeshi Hisada

http://www.w3.org/2001/XMLSchema#string

Tetsunari Oyama

http://www.w3.org/2001/XMLSchema#string

Yoshio Tomizawa

http://www.w3.org/2001/XMLSchema#string

Yosuke Miura

http://www.w3.org/2001/XMLSchema#string

P2860

TUBB3/βIII-tubulin acts through the PTEN/AKT signaling axis to promote tumorigenesis and anoikis resistance in non-small cell lung cancer

betaIII-tubulin is a multifunctional protein involved in drug sensitivity and tumorigenesis in non-small cell lung cancer

Class III beta-tubulin isotype predicts response in advanced breast cancer patients randomly treated either with single-agent doxorubicin or docetaxel

Werner's syndrome lymphoblastoid cells are hypersensitive to topoisomerase II inhibitors in the G2 phase of the cell cycle

Topoisomerase levels determine chemotherapy responsein vitroandin vivo

Class III β-tubulin is a predictive marker for taxane-based chemotherapy in recurrent and metastatic gastric cancer

Class III beta-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients.

TOP2Ahigh is the phenotype of recurrence and metastasis whereas TOP2Aneg cells represent cancer stem cells in prostate cancer.

Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma

βIII-tubulin: a novel mediator of chemoresistance and metastases in pancreatic cancer

P304

2369-2378

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2017.6419

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28789453

http://www.w3.org/2001/XMLSchema#string

P932

5530002

http://www.w3.org/2001/XMLSchema#string